<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36466050</PMID><DateRevised><Year>2022</Year><Month>12</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1028-6276</ISSN><JournalIssue CitedMedium="Print"><Volume>46</Volume><Issue>6</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Iranian journal of science and technology. Transaction A, Science</Title><ISOAbbreviation>Iran J Sci Technol Trans A Sci</ISOAbbreviation></Journal><ArticleTitle>The Trend of IgG and IgM Antibodies During 6-Month Period After the Disease Episode in COVID-19 Patients.</ArticleTitle><Pagination><StartPage>1555</StartPage><EndPage>1562</EndPage><MedlinePgn>1555-1562</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40995-022-01382-7</ELocationID><Abstract><AbstractText Label="UNLABELLED">SARS-CoV-2 is a newly emerged coronavirus that has been widely transmitted since late 2019. It has caused a pandemic and infected roughly 450 million people globally.Hitherto, there is no approved anti-COVID-19 treatment, and vaccination is the only experienced preventive strategy. It mainly promotes the immune system, which is vital as a barrier against COVID-19. Humoral immunity (antibody-mediated immunity), among the various functions of the immune system against the coronavirus, plays an outstanding role in preventing infection. Consequently, we intended to assess IgG and IgM antibodies, 3 and 6&#xa0;months after infection, to trend their titer and see how long COVID-19 antibodies remained in the human body. According to the research-designed criteria, only 98 patients out of 4500 suspected cases of SARS-CoV-2 infection remained for analysis. Blood samples were taken in three time periods (Day Zero (<i>T</i> <sub>0</sub>), 3 and 6&#xa0;months post-infection) and examined for COVID-19's IgG and IgM antibodies titration using the ELISA platform. Though both IgG and IgM were still detectable for some subjects at the end of the period, the decline in their levels (from 14.45&#x2009;&#xb1;&#x2009;5.88 to 2.52&#x2009;&#xb1;&#x2009;2.33 for IgG [85% decline of antibody titer] and 8.3&#x2009;&#xb1;&#x2009;0.99 to 0.37&#x2009;&#xb1;&#x2009;0.14 for IgM [95.5% decline of antibody titer]) was statistically significant (<i>P</i> value 0.0001). There was no correlation between gender and IgG and IgM levels. Although the levels of both antibodies were overall higher in the senior group (&#x2265;&#x2009;60&#xa0;years old), statistical analysis showed a significantly higher level just for IgM in this group (<i>P</i> value: 0.005). Following the results, although anti-SARS-CoV-2 IgM and IgG antibodies can persist in the blood for 6&#xa0;months post-infection, their levels steeply declined over time. Therefore, relying on humoral immunity as a trustworthy barrier against SARS-CoV-2 infection calls for more extensive research.</AbstractText><AbstractText Label="SUPPLEMENTARY INFORMATION" NlmCategory="UNASSIGNED">The online version contains supplementary material available at 10.1007/s40995-022-01382-7.</AbstractText><CopyrightInformation>&#xa9; The Author(s), under exclusive licence to Shiraz University 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ghasemi</LastName><ForeName>Darioush</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.</Affiliation><Identifier Source="GRID">grid.411521.2</Identifier><Identifier Source="ISNI">0000 0000 9975 294X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Araeynejad</LastName><ForeName>Faridoddin</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Jannat Clinical Laboratory, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maghsoud</LastName><ForeName>Omid</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>R&amp;D Department, Enzymezist Research and Production Company, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerami</LastName><ForeName>Nafiseh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Jannat Clinical Laboratory, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keihan</LastName><ForeName>Amir Homayoun</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.</Affiliation><Identifier Source="GRID">grid.411521.2</Identifier><Identifier Source="ISNI">0000 0000 9975 294X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rezaie</LastName><ForeName>Ehsan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.</Affiliation><Identifier Source="GRID">grid.411521.2</Identifier><Identifier Source="ISNI">0000 0000 9975 294X</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehdizadeh</LastName><ForeName>Saber</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation><Identifier Source="GRID">grid.411746.1</Identifier><Identifier Source="ISNI">0000 0004 4911 7066</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosseinzadeh</LastName><ForeName>Ramin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation><Identifier Source="GRID">grid.411583.a</Identifier><Identifier Source="ISNI">0000 0001 2198 6209</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammadi</LastName><ForeName>Ramtin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran.</Affiliation><Identifier Source="GRID">grid.411463.5</Identifier><Identifier Source="ISNI">0000 0001 0706 2472</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahardoust</LastName><ForeName>Mansour</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health and safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation><Identifier Source="GRID">grid.411600.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heiat</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9982-2773</Identifier><AffiliationInfo><Affiliation>Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, Iran.</Affiliation><Identifier Source="GRID">grid.411521.2</Identifier><Identifier Source="ISNI">0000 0000 9975 294X</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Iran</Country><MedlineTA>Iran J Sci Technol Trans A Sci</MedlineTA><NlmUniqueID>101613324</NlmUniqueID><ISSNLinking>1028-6276</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">ELISA</Keyword><Keyword MajorTopicYN="N">IgG</Keyword><Keyword MajorTopicYN="N">IgM</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Conflict of interestThe authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>5</Day><Hour>3</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36466050</ArticleId><ArticleId IdType="pmc">PMC9702912</ArticleId><ArticleId IdType="doi">10.1007/s40995-022-01382-7</ArticleId><ArticleId IdType="pii">1382</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agache I, Song Y, Posso M, Alonso-Coello P, Rocha C, Sol&#xe0; I, Beltran J, Akdis CA, Akdis M, Brockow K. Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI Biologicals Guidelines. Allergy. 2021;76:45&#x2013;58. doi: 10.1111/all.14510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14510</ArticleId><ArticleId IdType="pubmed">32691892</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonyaratanakornkit J, Morishima C, Selke S, Zamora D, McGuffin S, Shapiro AE, Campbell VL, McClurkan CL, Jing L, Gross R. Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 after COVID-19. MedRxiv. 2020 doi: 10.1101/2020.10.06.20207472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.06.20207472</ArticleId><ArticleId IdType="pmc">PMC7843229</ArticleId><ArticleId IdType="pubmed">33320842</ArticleId></ArticleIdList></Reference><Reference><Citation>De Donno A, Lobreglio G, Panico A, Grassi T, Bagordo F, Bozzetti MP, Massari S, Siculella L, Damiano F, Guerra F. IgM and IgG profiles reveal peculiar features of humoral immunity response to SARS-CoV-2 infection. Int J Environ Res Public Health. 2021;18:1318. doi: 10.3390/ijerph18031318.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18031318</ArticleId><ArticleId IdType="pmc">PMC7908175</ArticleId><ArticleId IdType="pubmed">33535692</ArticleId></ArticleIdList></Reference><Reference><Citation>Dispinseri S, Secchi M, Pirillo MF, Tolazzi M, Borghi M, Brigatti C, De Angelis ML, Baratella M, Bazzigaluppi E, Venturi G. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nat Commun. 2021;12:1&#x2013;12. doi: 10.1038/s41467-021-22958-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22958-8</ArticleId><ArticleId IdType="pmc">PMC8113594</ArticleId><ArticleId IdType="pubmed">33976165</ArticleId></ArticleIdList></Reference><Reference><Citation>GeurtsvanKessel CH, Okba N, Igloi Z, Bogers S, Embregts CW, Laksono BM, Leijten L, Rokx C, Rijnders B, Rahamat-Langendoen J. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment. Nat Commun. 2020;11:1&#x2013;5. doi: 10.1038/s41467-020-17317-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17317-y</ArticleId><ArticleId IdType="pmc">PMC7338506</ArticleId><ArticleId IdType="pubmed">32632160</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/s0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassauni&#xe8;re R, Frische A, Harboe ZB, Nielsen AC, Fomsgaard A, Krogfelt KA, J&#xf8;rgensen CS (2020) Evaluation of nine commercial SARS-CoV-2 immunoassays. MedRxiv</Citation></Reference><Reference><Citation>Lee CY-P, Lin RT, Renia L, Ng LF. Serological approaches for COVID-19: epidemiologic perspective on surveillance and control. Front Immunol. 2020;11:879. doi: 10.3389/fimmu.2020.00879.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00879</ArticleId><ArticleId IdType="pmc">PMC7194125</ArticleId><ArticleId IdType="pubmed">32391022</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, Sun R, Wang Y, Hu B, Chen W, Zhang Y, Wang J, Huang B, Lin Y, Yang J, Cai W, Wang X, Cheng J, Chen Z, Sun K, Pan W, Zhan Z, Chen L, Ye F. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol. 2020;92:1518&#x2013;1524. doi: 10.1002/jmv.25727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25727</ArticleId><ArticleId IdType="pmc">PMC7228300</ArticleId><ArticleId IdType="pubmed">32104917</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Han H, Liu F, Lv Z, Wu K, Liu Y, Feng Y, Zhu C. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020. Clin Chim Acta. 2020;505:172&#x2013;175. doi: 10.1016/j.cca.2020.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.03.009</ArticleId><ArticleId IdType="pmc">PMC7094385</ArticleId><ArticleId IdType="pubmed">32156607</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, Zhang Z, Wang L, Peng L, Chen L, Qin Y, Zhao D, Tan S, Yin L, Xu J, Zhou C, Jiang C, Liu L. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63:364&#x2013;374. doi: 10.1007/s11427-020-1643-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-020-1643-8</ArticleId><ArticleId IdType="pmc">PMC7088566</ArticleId><ArticleId IdType="pubmed">32048163</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020;92:401&#x2013;402. doi: 10.1002/jmv.25678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25678</ArticleId><ArticleId IdType="pmc">PMC7166628</ArticleId><ArticleId IdType="pubmed">31950516</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C, Liu M, Li Q, Zheng X, Ai W, Gong F, Fan J, Liu S, Wang X, Luo J. Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: analysis of multiple factors. Int J Infect Dis. 2021;108:57&#x2013;62. doi: 10.1016/j.ijid.2021.04.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.04.078</ArticleId><ArticleId IdType="pmc">PMC8080494</ArticleId><ArticleId IdType="pubmed">33932603</ArticleId></ArticleIdList></Reference><Reference><Citation>Maine GN, Lao KM, Krishnan SM, Afolayan-Oloye O, Fatemi S, Kumar S, VanHorn L, Hurand A, Sykes E, Sun Q. Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect. J Clin Virol. 2020;133:104663. doi: 10.1016/j.jcv.2020.104663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104663</ArticleId><ArticleId IdType="pmc">PMC7590643</ArticleId><ArticleId IdType="pubmed">33161369</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon V, Shariff MA, Gutierrez VP, Carre&#xf1;o JM, Yu B, Jawed M, Gossai M, Valdez E, Pillai A, Venugopal U. Longitudinal humoral antibody response to SARS-CoV-2 infection among healthcare workers in a New York City hospital. BMJ Open. 2021;11:e051045. doi: 10.1136/bmjopen-2021-051045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-051045</ArticleId><ArticleId IdType="pmc">PMC8550870</ArticleId><ArticleId IdType="pubmed">34702729</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastawicki W, Rokosz-Chudziak N. Characteristics and assessment of the usefulness of serological tests in the diagnostic of infections caused by coronavirus SARS-CoV-2 on the basis of available manufacturer's data and literature review. Przegl Epidemiol. 2020;74:49&#x2013;68. doi: 10.32394/pe.74.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.32394/pe.74.11</ArticleId><ArticleId IdType="pubmed">32500987</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaie E, Nekoie H, Miri A, Oulad G, Ahmadi A, Saadati M, Bozorgmehr M, Ebrahimi M, Salimian J. Different frequencies of memory B-cells induced by tetanus, botulinum, and heat-labile toxin binding domains. Microb Pathog. 2019;127:225&#x2013;232. doi: 10.1016/j.micpath.2018.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2018.12.003</ArticleId><ArticleId IdType="pubmed">30528250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846&#x2013;848. doi: 10.1007/s00134-020-05991-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidiq Z, Hanif M, Dwivedi KK, Chopra K. Benefits and limitations of serological assays in COVID-19 infection. Indian J Tuberculosis. 2020;67:S163&#x2013;S66. doi: 10.1016/j.ijtb.2020.07.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijtb.2020.07.034</ArticleId><ArticleId IdType="pmc">PMC7409828</ArticleId><ArticleId IdType="pubmed">33308664</ArticleId></ArticleIdList></Reference><Reference><Citation>Song KH, Kim DM, Lee H, Ham SY, Oh SM, Jeong H, Jung J, Kang CK, Park JY, Kang YM, Kim JY, Park JS, Park KU, Kim ES, Kim HB. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19. Korean J Intern Med. 2021;36:11&#x2013;14. doi: 10.3904/kjim.2020.325.</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjim.2020.325</ArticleId><ArticleId IdType="pmc">PMC7820639</ArticleId><ArticleId IdType="pubmed">32972123</ArticleId></ArticleIdList></Reference><Reference><Citation>To KK-W, Tsang OT-Y, Leung W-S, Tam AR, Wu T-C, Lung DC, Yip CC-Y, Cai J-P, Chan JM-C, Chik TS-H. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20:565&#x2013;574. doi: 10.1016/S1473-3099(20)30196-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30196-1</ArticleId><ArticleId IdType="pmc">PMC7158907</ArticleId><ArticleId IdType="pubmed">32213337</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Ai J, Loeffelholz MJ, Tang Y-W, Zhang W. Meta-analysis of diagnostic performance of serology tests for COVID-19: impact of assay design and post-symptom-onset intervals. Emerg Microbes Infect. 2020;9:2200&#x2013;2211. doi: 10.1080/22221751.2020.1826362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1826362</ArticleId><ArticleId IdType="pmc">PMC7580610</ArticleId><ArticleId IdType="pubmed">32962560</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff F, Dahma H, Duterme C, Van den Wijngaert S, Vandenberg O, Cotton F, Montesinos I. Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays. Diagn Microbiol Infect Dis. 2020;98:115140. doi: 10.1016/j.diagmicrobio.2020.115140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2020.115140</ArticleId><ArticleId IdType="pmc">PMC7354376</ArticleId><ArticleId IdType="pubmed">32829098</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Ding C, Li J, Wang Y, Guo H, Lu Z, Wang J, Zheng C, Jin T, Gao Y, He H. Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test. J Med Virol. 2020;92:2004&#x2013;2010. doi: 10.1002/jmv.25930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25930</ArticleId><ArticleId IdType="pmc">PMC7264659</ArticleId><ArticleId IdType="pubmed">32330303</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270&#x2013;273. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>